Capital Research Global Investors Stryker Corp Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Stryker Corp stock. As of the latest transaction made, Capital Research Global Investors holds 9,982,717 shares of SYK stock, worth $3.4 Billion. This represents 0.83% of its overall portfolio holdings.
Number of Shares
9,982,717
Previous 10,205,488
2.18%
Holding current value
$3.4 Billion
Previous $3.06 Billion
16.9%
% of portfolio
0.83%
Previous 0.77%
Shares
27 transactions
Others Institutions Holding SYK
# of Institutions
2,128Shares Held
280MCall Options Held
1.19MPut Options Held
710K-
Vanguard Group Inc Valley Forge, PA31.5MShares$10.7 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY26.2MShares$8.93 Billion0.22% of portfolio
-
Greenleaf Trust Kalamazoo, MI18.6MShares$6.33 Billion62.06% of portfolio
-
State Street Corp Boston, MA14.4MShares$4.88 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.9MShares$4.04 Billion0.52% of portfolio
About STRYKER CORP
- Ticker SYK
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 378,320,992
- Market Cap $129B
- Description
- Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...